Adv. Oded Bejarano practice is in  hi-tech and venture capital, and mergers and acquisitions. Oded focuses on fund formation, public financings and private placements, and representation of technology companies. Oded is also deals with multi-national M&As.

Oded represents Giza V Fund, Accelmed Partners II, Rimonim Agro Fund, Brainsway (NASDAQ $ TASE: BWAY), Wolt in its activity in Israel, and Creso Pharma and Roots Sustainable Technologies traded on ASX. Oded dealt with a number of Israeli companies that offered their shares on Nasdaq, including Sol-Gel Technologies, Brainsway, Tufin Software Technologies and Redhill Biopharma.

Oded joined GKH in 2017. Prior to joining GKH Oded worked at prominent corporate law firms in Tel-Aviv and in London, among them White & Case in London. Oded is a licensed lawyer in Israel and in England & Wales.